Cargando…

Glucagon-Like Peptide-1 Receptor Ligand Interactions: Structural Cross Talk between Ligands and the Extracellular Domain

Activation of the glucagon-like peptide-1 receptor (GLP-1R) in pancreatic β-cells potentiates insulin production and is a current therapeutic target for the treatment of type 2 diabetes mellitus (T2DM). Like other class B G protein-coupled receptors (GPCRs), the GLP-1R contains an N-terminal extrace...

Descripción completa

Detalles Bibliográficos
Autores principales:	West, Graham M., Willard, Francis S., Sloop, Kyle W., Showalter, Aaron D., Pascal, Bruce D., Griffin, Patrick R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152014/ https://www.ncbi.nlm.nih.gov/pubmed/25180755 http://dx.doi.org/10.1371/journal.pone.0105683

Ejemplares similares

Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
por: Willard, Francis S., et al.
Publicado: (2012)

Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles
por: Bueno, Ana B., et al.
Publicado: (2016)

Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor
por: Willard, Francis S., et al.
Publicado: (2012)

Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets
por: Sloop, Kyle W., et al.
Publicado: (2010)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands
por: Tanday, Neil, et al.
Publicado: (2021)

Biophysical screening methods for extracellular domain peptide receptors, application to natriuretic peptide receptor C ligands
por: Conole, Daniel, et al.
Publicado: (2018)

An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain
por: Yin, Yanting, et al.
Publicado: (2016)

Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors
por: Michaloski, Jussara S., et al.
Publicado: (2016)

Structural and Molecular Conservation of Glucagon-Like Peptide-1 and Its Receptor Confers Selective Ligand-Receptor Interaction
por: Moon, Mi Jin, et al.
Publicado: (2012)

Asn‐linked N–acetylglucosamine of the amylin receptor 2 extracellular domain enhances peptide ligand affinity
por: Lee, Sangmin
Publicado: (2020)

Discrepancy between the Actions of Glucagon-like Peptide-1 Receptor Ligands in the Protection of the Heart against Ischemia Reperfusion Injury
por: Ismaeil, Ali, et al.
Publicado: (2022)

Single-molecule analysis reveals that a glucagon-bound extracellular domain of the glucagon receptor is dynamic
por: Liu, Ting, et al.
Publicado: (2023)

Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
por: Conceição-Furber, Ellen, et al.
Publicado: (2022)

CrossTalkeR: analysis and visualization of ligand–receptorne tworks
por: Nagai, James S, et al.
Publicado: (2021)

Molecular dynamics simulations and in silico peptide ligand screening of the Elk-1 ETS domain
por: Hussain, Abrar, et al.
Publicado: (2011)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Glucagon‐like peptide‐1 receptor agonist prescribing patterns in adolescents with type 2 diabetes
por: Bensignor, Megan O., et al.
Publicado: (2022)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Olfactory imprinting is triggered by MHC peptide ligands
por: Hinz, Cornelia, et al.
Publicado: (2013)

Chemically Modified Peptide Scaffolds Target the CFTR-Associated Ligand PDZ Domain
por: Amacher, Jeanine F., et al.
Publicado: (2014)

Structural properties and peptide ligand binding of the capsid homology domains of human Arc
por: Hallin, Erik I., et al.
Publicado: (2021)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains
por: Huang, Wei, et al.
Publicado: (2018)

Peptide–polymer ligands for a tandem WW-domain, an adaptive multivalent protein–protein interaction: lessons on the thermodynamic fitness of flexible ligands
por: Koschek, Katharina, et al.
Publicado: (2015)

Structural Dynamics of the Cereblon Ligand Binding Domain
por: Hartmann, Marcus D., et al.
Publicado: (2015)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
por: Ammann, Markus, et al.
Publicado: (2023)

Modeling the binding of diverse ligands within the Ah receptor ligand binding domain
por: Giani Tagliabue, Sara, et al.
Publicado: (2019)

GABA(A) Receptor Ligands Often Interact with Binding Sites in the Transmembrane Domain and in the Extracellular Domain—Can the Promiscuity Code Be Cracked?
por: Iorio, Maria Teresa, et al.
Publicado: (2020)

Ataxin-3 Is a Multivalent Ligand for the Parkin Ubl Domain
por: Bai, Jane J., et al.
Publicado: (2013)

Ligand Binding Induces Agonistic-Like Conformational Adaptations in Helix 12 of Progesterone Receptor Ligand Binding Domain
por: Zheng, Liangzhen, et al.
Publicado: (2019)

Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011)

Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2
por: Hsiao, Ku-chuan, et al.
Publicado: (2003)

ERRATUM: Olfactory imprinting is triggered by MHC peptide ligands
por: Hinz, Cornelia, et al.
Publicado: (2014)

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
por: Mulvihill, Erin E.
Publicado: (2018)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Glucagon-like peptide 1 and Glucagon-like peptide 2 in relation to osteoporosis in non-diabetic postmenopausal women
por: Montes Castillo, María Cristina, et al.
Publicado: (2019)

Discovery of peptide ligands targeting a specific ubiquitin-like domain–binding site in the deubiquitinase USP11
por: Spiliotopoulos, Anastasios, et al.
Publicado: (2019)

Identification of Peptide Mimotope Ligands for Natalizumab
por: Ruff, Laura E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_55itcjgaluv3lv94l711vafuju